Ş. Iorga

发表

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.

A. Maggioni, M. Arca, A. Catapano, 2018, Atherosclerosis.

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease

S. Rossetti, C. Blanchette, B. Gutierrez, 2014 .

Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population

D. Furst, A. Clarke, D. Furst, 2013, Lupus.

Lifetime Costs for Treated Follicular Lymphoma Patients in the US

T. Delea, R. Maziarz, Q. Ma, 2021, PharmacoEconomics.

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.

Dylan L. Steen, J. Ferrières, D. Ansell, 2018, Clinical therapeutics.

Epidemiology of Systemic Sclerosis in a Large US Managed Care Population

D. Furst, A. Fernandes, T. Bancroft, 2012, The Journal of Rheumatology.

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

A. Zaidi, Soyon Lee, E. Morris, 2021, Orphanet Journal of Rare Diseases.

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.

W. März, D. Ansell, K. Theobald, 2018, Atherosclerosis.

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

N. Wong, Ş. Iorga, Miraj Y. Patel, 2020, American journal of preventive cardiology.

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

T. Bancroft, Ş. Iorga, M. Sikirica, 2014, BMC Health Services Research.

Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population

D. Furst, A. Fernandes, T. Bancroft, 2012, The Journal of Rheumatology.

Systemic Sclerosis in an Insured Population Annual Medical Costs and Healthcare Resource Use in Patients with and

D. Furst, A. Fernandes, T. Bancroft, 2012 .

Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.

Matthew K. Ito, D. Karalis, K. Azar, 2020, Journal of clinical lipidology.

Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan

D. Furst, A. Amato, K. Gajria, 2012, Muscle & nerve.

Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population

D. Furst, A. Clarke, K. Gajria, 2013, Journal of medical economics.

Medical costs and health‐care resource use in patients with inflammatory myopathies in an insured population

D. Furst, A. Amato, A. Fernandes, 2012, Muscle & nerve.

Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients

K. Ramaswamy, S. Panjabi, J. Swindle, 2011, Current medical research and opinion.